Pharmaceutical Market Europe • February 2026 • 5
CONTENTS
FEBRUARY 2026
NEWS & COLUMNS
J&J’s Darzalex Faspro regimen approved by FDA; Biogen’s litifilimab gets FDA Breakthrough Therapy Designation
8-9 NEWS
GSK’s Arexvy RSV vaccine receives expanded EC approval; AZ’s Imfinzi regimen gets positive CHMP opinion
10-11 DERMATOLOGY NEWS
Sanofi’s amlitelimab in atopic dermatitis; LEO Pharma’s Anzupgo phase 3 trial
12 DARWIN’S MEDICINE
Pharma’s AI revolution may hinder innovation
13 LIFELINE
Become part of the bigger AMR chorus
14 BUILDING DECISION FITNESS
The Top 10 pharma business simulations
15 WHEN PATIENTS ASK AI FIRST
Ensuring credibility and transparency
FEATURES
16-17 THE 2025 MOST STUDIED DISEASES REPORT
The report tracks the world’s most studied diseases using contextualised real-world data from more than 300 million patients. This year’s report was based on 65,892 recruiting clinical trials from across the globe
18-19 PATIENT-CENTRICITY IN RARE DISEASE: THE PATH TO TREATMENT
More than 300 million people worldwide live with a rare disease, representing up to 5.9% of the global population, yet rare disease patients are frequently isolated, navigating a disjointed path before receiving a correct diagnosis
20-22 HOW DYNAMIC CAPABILITIES ENABLE ADAPTATION TO VUCA MARKETS
‘VUCA’ is military jargon that stands for ‘volatile, uncertain, complex and ambiguous’, but it fits our industry uncomfortably well. Pharma, medtech and related sectors are all those things, which creates a fundamental challenge
COMMUNIQUE
MARKETING & COMMS
28-30 THE RACE TO EXPLORE AND HARNESS GENAI IN HEALTHCARE
GenAI’s reach into healthcare is becoming more comprehensive, with most organisations using some form of AI and actively looking at expanding its digital footprint. It’s been progressing through ever-advancing digital tools and capabilities over the last decade, with the market for GenAI expected to rise from $1.1bn to £17.2bn by 2032
34-36 GENAI: EMBRACING THE TRANSFORMATION – WITH CAUTION
Agility in crowded, rapidly-shifting markets is essential and the growing efficacy of large language models and algorithms is a beguiling prospect but, despite the GenAI fervour, key observers feel there is an acute need to prepare organisations to understand what specific tools they need and how to wield them
39 HEALTHCARE COMMS
Cuttsy+Cuttsy becomes employee-owned; Edelman’s Katie Halajko appointed as Founding Member of the AI in Media Institute.
CAREERS & RECRUITMENT
40 APPOINTMENTS
Each month, we bring you the latest news on job changes in the pharma sector. This month, we are highlighting change at Eli Lilly, Ipsen and Accord Healthcare
6 J&J'S DARZALEX FASPRO REGIMEN APPROVED BY FDA
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services